🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
NTQ5082 capsule is a small molecule CFB factor inhibitor. The study is a ra...
Status
Not Yet Recruiting
Location
The Third hospital of Changsha
Start Date
2024-08
Trial ID
NCT06558656
Treatments Being Tested
NTQ5082 is a small molecule inhibitor of complement factor B (CFB) that inh...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05
Trial ID
NCT06982040
Treatments Being Tested
NTQ5082 capsule is a small molecule CFB factor inhibitor. The study is a ra...
Status
Not Yet Recruiting
Location
The Third hospital of Changsha
Start Date
2024-08
Trial ID
NCT06560593
This is a single-center, non-randomized, open-label, single-sequence, self-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-30
Trial ID
NCT07745439
NTQ5082 capsules are a small molecule CFB inhibitor. This study is a multic...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences ,
Start Date
2026-06
Trial ID
NCT07177872
Treatments Being Tested
NTQ5082 capsules are a small molecule CFB inhibitor. This study is a multic...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2025-11
Trial ID
NCT07177859
Treatments Being Tested
NTQ5082 capsule is a small molecule CFB factor inhibitor. This study is a m...
Status
Active Not Recruiting
Location
Hematology Hospital of the Chinese Academy of Medical Sciences
Start Date
2025-01-23
Trial ID
NCT06764303
Treatments Being Tested